首页> 外文期刊>The economist >A puff of logic
【24h】

A puff of logic

机译:一点逻辑

获取原文
获取原文并翻译 | 示例
           

摘要

That cannabis and schizophrenia are linked is widely accepted. Several studies suggest the drug can set off short-term psychotic episodes in those already suffering from the condition. Other research, though, does more than this. It shows that people with schizophrenia are twice as likely as others to use cannabis. This leads some to argue that the drug is actually a cause of schizophrenia rather than just a trigger-a line of evidence sometimes employed by those who wish to keep it illegal. But there is another possible explanation for the association. This is that schizophrenics are, for some reason, more drawn to the stuff in the first place. And support for this idea has just been published in Molecular Psychiatry by Robert Power of King's College, London, and his colleagues. Their work suggests that people who have gene types associated with schizophrenia, even ones who do not have symptoms, are more likely to take cannabis.
机译:大麻和精神分裂症之间的联系已被广泛接受。几项研究表明,该药可以在已经患有该病的人中引起短期精神病发作。但是,其他研究的作用远不止于此。它表明患有精神分裂症的人使用大麻的可能性是其他人的两倍。这导致一些人争辩说,该药物实际上是精神分裂症的起因,而不仅仅是引发因素-一些希望将其保持非法的人有时会使用这些证据。但是对于这种关联还有另一种可能的解释。出于某种原因,这是精神分裂症患者首先被吸引的原因。伦敦金斯学院的罗伯特·鲍尔(Robert Power)及其同事在分子精神病学杂志上发表了对该想法的支持。他们的工作表明,具有与精神分裂症相关的基因类型的人,即使没有症状的人,也更可能服用大麻。

著录项

  • 来源
    《The economist》 |2014年第8893期|75-75|共1页
  • 作者

  • 作者单位
  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号